- Home
- BEEP vs TIL Comparison
BEEP vs TIL Comparison
Compare BEEP & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEEP
- TIL
- Stock Information
- Founded
- BEEP 2015
- TIL 2018
- Country
- BEEP United States
- TIL United States
- Employees
- BEEP N/A
- TIL N/A
- Industry
- BEEP Blank Checks
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- BEEP Finance
- TIL Health Care
- Exchange
- BEEP Nasdaq
- TIL Nasdaq
- Market Cap
- BEEP 162.0M
- TIL 171.7M
- IPO Year
- BEEP N/A
- TIL 2021
- Fundamental
- Price
- BEEP $3.93
- TIL $26.95
- Analyst Decision
- BEEP Strong Buy
- TIL Buy
- Analyst Count
- BEEP 2
- TIL 5
- Target Price
- BEEP $6.75
- TIL $119.00
- AVG Volume (30 Days)
- BEEP 22.3K
- TIL 316.4K
- Earning Date
- BEEP 05-12-2025
- TIL 05-13-2025
- Dividend Yield
- BEEP N/A
- TIL N/A
- EPS Growth
- BEEP N/A
- TIL N/A
- EPS
- BEEP N/A
- TIL N/A
- Revenue
- BEEP $36,416,000.00
- TIL N/A
- Revenue This Year
- BEEP $5.22
- TIL N/A
- Revenue Next Year
- BEEP $5.13
- TIL N/A
- P/E Ratio
- BEEP N/A
- TIL N/A
- Revenue Growth
- BEEP 13.81
- TIL N/A
- 52 Week Low
- BEEP $2.48
- TIL $9.62
- 52 Week High
- BEEP $4.86
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- BEEP 48.41
- TIL 65.08
- Support Level
- BEEP $3.73
- TIL $12.60
- Resistance Level
- BEEP $4.15
- TIL $35.28
- Average True Range (ATR)
- BEEP 0.29
- TIL 3.84
- MACD
- BEEP 0.01
- TIL 1.60
- Stochastic Oscillator
- BEEP 60.94
- TIL 63.27
About BEEP Mobile Infrastructure Corporation
Mobile Infrastructure Corp focuses on acquiring, owning, and leasing parking facilities and related infrastructure, including parking lots, parking garages and other parking structures throughout the United States. The company owns forty three parking facilities in twenty one separate markets throughout the United States, with a total of approximately fifteen thousand seven hundred parking spaces. It operates in a single reportable segment: parking. The company derives majority of revenue from Percentage rental income.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.